Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04117217 · ClinicalTrials.gov registry record
Risk Factors for Thrombosis in Children With Central Venous Lines
A clinical trial, sponsored by University of Arizona.
- Completed
- Registry status
- 200
- Enrollment target
NCT04117217 is a clinical trial that has completed, run by University of Arizona. The registered enrollment target is 200 participants.
The verdict
NCT04117217 has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This project addresses the role of lab markers around the time of central line placement in predicting risk of thrombosis in pediatric patients with central venous lines being placed. The project proposes an innovative way to predict higher risk of thrombosis in the pediatric population to give clinicians a valid tool to guide clinical practice for these patients.
Interventions
- DIAGNOSTIC_TEST Labs drawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04117217
The ClinicalTrials.gov registry entry for NCT04117217 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Labs drawn is the first listed.
NCT04117217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04117217 about?
NCT04117217 is a clinical study titled "Risk Factors for Thrombosis in Children With Central Venous Lines". This project addresses the role of lab markers around the time of central line placement in predicting risk of thrombosis in pediatric patients with central venous lines being placed. The project proposes an innovative way to predict higher risk of thrombosis in the pediatric population to give clin...
What is the current status of trial NCT04117217?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-03-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04117217?
The interventions under investigation include: Labs drawn (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04117217?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.